Search research articles
Contact Us
Filters
Showing results (41-50 of 87) with videos related to
Page
of 9
Sort By:
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
September 19, 2018
Using "Big Data" in the Cost-Effectiveness Analysis of Next-Generation Sequencing Technologies: Challenges and Potential Solutions
Sarah Wordsworth, Brett Doble, Katherine Payne, et al.
Therapeutic Innovation & Regulatory Science
|
March 17, 2021
Interdisciplinary Safety Evaluation for Learning and Decision-Making
Greg Ball, Barbara A Hendrickson, Amy L Freedman, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
May 12, 2020
Addressing Challenges of Economic Evaluation in Precision Medicine Using Dynamic Simulation Modeling
Deborah A Marshall, Luiza R Grazziotin, Dean A Regier, et al.
Therapeutic Innovation & Regulatory Science
|
June 20, 2020
A Framework for Safety Evaluation Throughout the Product Development Life-Cycle
Greg Ball, Tjark Reblin, James Buchanan, et al.
Pharmacoeconomics
|
August 2, 2017
Using Genomic Information to Guide Ibrutinib Treatment Decisions in Chronic Lymphocytic Leukaemia: A Cost-Effectiveness Analysis
James Buchanan, Sarah Wordsworth, Ruth Clifford, et al.
Lung Cancer (Amsterdam, Netherlands)
|
January 11, 2021
Vaping and lung cancer - A review of current data and recommendations
Dara Bracken-Clarke, Dhruv Kapoor, Anne Marie Baird, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
May 19, 2026
The Costs of Genomic Newborn Screening in England: A Micro-Costing Analysis from the Generation Study
Martin Vu, Sigrún Eyrúnardóttir Clark, Katie Gilchrist, et al.
Health Economics
|
February 23, 2022
Eliciting risk preferences that predict risky health behavior: A comparison of two approaches
Murong Yang, Laurence S J Roope, James Buchanan, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
September 19, 2018
Methodological Issues in Assessing the Economic Value of Next-Generation Sequencing Tests: Many Challenges and Not Enough Solutions
Kathryn A Phillips, Patricia A Deverka, Deborah A Marshall, et al.
British Journal of Cancer
|
December 1, 2025
Correction: Preferences for multi-cancer tests (MCTs) in primary care: discrete choice experiments of general practitioners and the general public in England
John Buckell, Nomalanga Madyiwa, Gail Hayward, et al.
Page
of 9
Search research articles
Search
Showing results (41-50 of 87) with videos related to
Sort By:
Page
of 9
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
September 19, 2018
Using "Big Data" in the Cost-Effectiveness Analysis of Next-Generation Sequencing Technologies: Challenges and Potential Solutions
Sarah Wordsworth, Brett Doble, Katherine Payne, et al.
Therapeutic Innovation & Regulatory Science
|
March 17, 2021
Interdisciplinary Safety Evaluation for Learning and Decision-Making
Greg Ball, Barbara A Hendrickson, Amy L Freedman, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
May 12, 2020
Addressing Challenges of Economic Evaluation in Precision Medicine Using Dynamic Simulation Modeling
Deborah A Marshall, Luiza R Grazziotin, Dean A Regier, et al.
Therapeutic Innovation & Regulatory Science
|
June 20, 2020
A Framework for Safety Evaluation Throughout the Product Development Life-Cycle
Greg Ball, Tjark Reblin, James Buchanan, et al.
Pharmacoeconomics
|
August 2, 2017
Using Genomic Information to Guide Ibrutinib Treatment Decisions in Chronic Lymphocytic Leukaemia: A Cost-Effectiveness Analysis
James Buchanan, Sarah Wordsworth, Ruth Clifford, et al.
Lung Cancer (Amsterdam, Netherlands)
|
January 11, 2021
Vaping and lung cancer - A review of current data and recommendations
Dara Bracken-Clarke, Dhruv Kapoor, Anne Marie Baird, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
May 19, 2026
The Costs of Genomic Newborn Screening in England: A Micro-Costing Analysis from the Generation Study
Martin Vu, Sigrún Eyrúnardóttir Clark, Katie Gilchrist, et al.
Health Economics
|
February 23, 2022
Eliciting risk preferences that predict risky health behavior: A comparison of two approaches
Murong Yang, Laurence S J Roope, James Buchanan, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
September 19, 2018
Methodological Issues in Assessing the Economic Value of Next-Generation Sequencing Tests: Many Challenges and Not Enough Solutions
Kathryn A Phillips, Patricia A Deverka, Deborah A Marshall, et al.
British Journal of Cancer
|
December 1, 2025
Correction: Preferences for multi-cancer tests (MCTs) in primary care: discrete choice experiments of general practitioners and the general public in England
John Buckell, Nomalanga Madyiwa, Gail Hayward, et al.
Page
of 9